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Abstract An antibacterial V11 kDa protein designated
chlamysin was isolated from viscera of the marine bivalve
Chlamys islandica. Chlamysin inhibited the growth of all Gram-
positive and Gram-negative bacteria tested. The isolated protein
was highly efficient in hydrolyzing Micrococcus luteus cells only
at low pH (4.5^6.2) and at low temperature (4^35‡C). No
significant loss of enzyme activity was observed after 30 days
storage at room temperature or after heating to 70‡C for 15 min,
suggesting relatively high protein structure stability. Sequence-
analyzed fragments of the protein revealed data which guided the
isolation of the cDNA gene, encoding a 137 amino acid
chlamysin precursor in scallops. The deduced protein contains
a high portion of cysteine, serine and histidine residues and has a
predicted isoelectric point below 7. The chlamysin protein was
found to have sequence homology to an isopeptidase and to a
recently published bivalve lysozyme.
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1. Introduction
Antimicrobial peptides and proteins are important compo-
nents of the innate defense in all species investigated [1]. Sev-
eral peptides with antibacterial e¡ect against various Gram-
positive and Gram-negative bacteria have been isolated from
marine invertebrates including horseshoe crab [2], shore crab
[3] and mollusks [4,5], and antibacterial proteins have been
isolated from sea hare [6,7] and from bivalve mollusks [8].
Marine bivalves are ¢lter feeders and free-living bacteria are
one of their major sources of nutrition. This implies that these
animals require a digestive system capable of degrading or
hydrolyzing prokaryotic cells in addition to the need of a
defense system against pathogenic bacteria. Not surprisingly,
lysozymes or lysozyme-like enzyme activities have been found
in many marine invertebrates including bivalves [9^12], and
these enzymes are believed to be involved in digestive pro-
cesses [9] as well as in host defense [13]. Two classes of lyso-
zyme, the chicken-type and the goose-type, have previously
been described in the animal kingdom (see [14] for a review),
and a new class was recently proposed to be contained by
invertebrate lysozymes [15]. Other types of lysozymes are
also seen in phages [16], bacteria [17] and plants [18]. Lyso-
zymes hydrolyze L-1,4-linked glycoside bonds of bacterial cell
wall peptidoglycans.
The Icelandic scallop Chlamys islandica is a marine species
located 20 m or deeper in the southern part of the arctic
region having sea temperatures rarely exceeding 4‡C. A puta-
tive lysozyme with high catalytic activity at low temperatures
was previously partly puri¢ed from an extract prepared from
the viscera of the scallop [11], and the extract was also found
to contain substances able to inhibit growth of ¢sh-pathogenic
bacteria in vitro [19]. This extract has now been further pro-
cessed and here we report biochemical and molecular charac-
teristics of the cold-active chlamysin, an antibacterial lyso-
zyme-like protein from Icelandic scallops.
2. Materials and methods
2.1. Puri¢cation of chlamysin, amino acid analysis and amino-terminal
sequencing
The material used was an extract prepared earlier from viscera of
the marine bivalve C. islandica [11]. The scallop viscera extract was
stored at 330‡C until use. After thawing at 8‡C, the extract was
brought to pH 4.8 by adding 6 N hydrochloric acid and then left
for settling of the produced £oc. The resulting supernatant was used
as crude extract for protein puri¢cation. All further steps in isolation
of chlamysin were carried out at 6^8‡C. The crude extract was mixed
with 3.5 volumes of 10 mM ammonium acetate bu¡er, pH 5.0, and
applied to a S Sepharose FF cation-exchange column (1 l; Pharmacia)
equilibrated with the same bu¡er. Fractions containing lysozyme-like
activity eluted at 0.4 M ammonium acetate, pH 6.0, were pooled and
then fractionated by ultra¢ltration on an Amicon CH2A ultra¢ltra-
tion unit ¢tted with an Amicon Hollow Fiber cartridge H1P 100-20
(cut o¡ 100 kDa). Permeates obtained were concentrated using an
Amicon Hollow Fiber cartridge H1P 10-43 (cut o¡ 10 kDa). The
retained solution was further concentrated on a PM 10 ultra¢lter
(cut o¡ 10 kDa), using an Amicon Dia£o stirred cell, and subse-
quently centrifuged at 14 000Ug for 20 min. The supernatant was
dialyzed against 10 mM ammonium acetate, pH 5.0, and subjected
to re-chromatography on a S Sepharose FF column (20 ml). Follow-
ing extensive washing with 20 mM ammonium acetate, pH 5.0, ab-
sorbed proteins were eluted by stepwise increasing concentrations of
ammonium acetate. Fractions with lysozyme-like activity eluted at
0.5 M ammonium acetate, pH 5.0, were dialyzed against 10 mM
ammonium acetate bu¡er, pH 6.0, and applied to a Blue Sepharose
CL-6B column (26 ml; Pharmacia). Active fractions released by
0.18 M ammonium acetate, pH 6.0, were concentrated by ultra¢ltra-
tion on a PM 10 ultra¢lter, followed by size-exclusion chromatogra-
phy on a Sephacryl S 200 HR column (493 ml; Pharmacia) equili-
brated with 0.1 M ammonium acetate bu¡er, pH 5.0. An aliquot from
each fraction containing lysozyme-like activity was subjected to so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
in the Phast System (Pharmacia) using precasted PhastGel Homoge-
neous High Density gels. Sample fractions showing a single protein
band of V11 kDa were pooled and the isolated protein, denoted
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chlamysin, was concentrated using a YM2 membrane disc (Amicon).
In total, 1.45 mg puri¢ed chlamysin was recovered from 30 l of scal-
lop viscera extract. Amino acid analysis was performed by composi-
tional analysis after vacuum hydrolysis. The hydrolysates were ana-
lyzed on an automatic amino acid analyzer Model 421 (Applied
Biosystems, Perkin Elmer). The N-terminal amino acid sequence of
chlamysin was analyzed by automatic Edman degradation using a
protein sequencer Model 477A (Applied Biosystems, Perkin Elmer)
and a G1005A N-terminal sequencer (Hewlett-Packard). The protein
was also reduced and alkylated with 4-vinyl-pyridine [20], and this
alkylated chlamysin was cleaved by cyanogen bromide (CNBr) and
the resulting polypeptides were separated by reversed-phase high per-
formance liquid chromatography (RP-HPLC) using a Pep-S C2/C18
column (Pharmacia) [21]. Peaks were collected and taken for Edman
degradation.
2.2. Enzyme assays
Activities of chlamysin and hen egg white lysozyme (HEWL) to-
wards lyophilized Micrococcus luteus cells (0.2 mg/ml) were measured
as previously described [11]. The activity was determined from the ¢rst
minute of linear decrease in absorbance at 450 nm. One unit of en-
zyme activity is de¢ned as the amount of enzyme that catalyzes a
decrease in absorbance of 0.001 min31. For determination of pH
for optimal activity, assay bu¡ers of 10 or 50 mM sodium acetate
and 5 or 20 mM sodium phosphate were used for pH ranges 3.6^5.6
and 6.0^8.0, respectively, after adjusting the bu¡er ionic strength us-
ing NaCl.
Chitinolytic activity was assayed using chitin-RBV (0.1 mg/ml) as
substrate in 50 mM sodium acetate bu¡er, pH 5.2, as described [22].
2.3. M. luteus cell wall digestion for product analysis
Suspensions of 2 mg M. luteus in 1 ml 0.1 M sodium acetate bu¡er,
pH 5.2, were incubated with 10 Wg of chlamysin or HEWL for 2 h at
24‡C. After incubation, the suspensions were centrifuged at 12 000Ug
for 10 min to remove undigested debris and the supernatants were
assayed for reducing groups [23] and for N-acetylamino sugars by the
acidic Morgan^Elson assay as described [24].
2.4. Antibacterial assays
In vitro antibacterial assays were performed following principles of
the microdilution technique [25]. All media used for growth inhibition
studies were prepared in 0.1 M sodium phosphate bu¡er, pH 6.2.
Listeria monocytogenes (CCMG 1452), Escherichia coli (ATCC
25922), Pseudomonas aeruginosa (ATCC 27853), Proteus mirabilis
(ATCC 35659), Staphylococcus epidermidis (ATCC 12228) and Entero-
coccus faecalis (ATCC 29212) were grown in tryptic soy broth, Bacil-
lus cereus (ATCC 10987) was grown in brain heart infusion medium
(Difco), and marine broth (Difco) was used to grow Vibrio salmoni-
cida (NCIMB 2245). Overnight bacterial cultures were diluted to give
103^105 colony forming units per ml. 100 Wl of diluted bacterial sus-
pensions was added to each microtiter plate well and combined with
11 Wl of chlamysin at concentrations obtained by 2-fold serial dilu-
tions made in 0.01% acetic acid and 0.2% bovine serum albumin. The
plates were incubated 24^48 h at 22‡C, or at 12‡C for V. salmonicida,
using a mixing device upon incubation. Cell growth was monitored by
measuring the absorbance at 620 nm using a SPECTRAmax Plus
Microplate Spectrophotometer (Molecular Devices). The minimal in-
hibitory concentration (MIC) was de¢ned as the lowest concentration
for which no bacterial growth was optically detectable.
2.5. mRNA isolation, cDNA synthesis and isolation of the chlamysin
gene
Six crystalline styles from freshly collected Islandic scallops were
dissected and mRNA was subsequently isolated using the PolyATract
System0 1000 (Promega). cDNA was synthesized by the use of the
Smart1 PCR cDNA Synthesis kit (Clontech). Degenerated oligonu-
cleotides chlaN4 (5P-GTWCCAGGMGCYTAYYTVGA-3P) and
chlaCT (5P-CCDGGGGGSCCSCCATTRTG-3P), identical to the
DNA sequences derived from the amino acid sequences obtained
from the puri¢ed chlamysin protein (see Fig. 1A), were utilized as
primers in ampli¢cation of a part of the chlamysin gene applying
the Advantage0 cDNA PCR kit (Clontech). The resulting 290 bp
PCR product of chlamysin was sequenced following the instructions
for the Thermo Sequenase1 Radiolabeled Terminator Cycle Sequenc-
ing kit (Amersham), exploiting the PCR primers as primers for se-
quencing. The sequence information was the basis for the design of
two intragenic oligonucleotides. These oligonucleotides CmarF (5P-
TTGACGTATACTCCGACTCGTGTGG-3P) and CmarR (5P-AG-
GTTCGTGAACACGAAGTATGGCC-3P) were applied as primers
in 3P- and 5P-random ampli¢cation of cDNA ends (RACE) reactions,
respectively, in combinations with the AP1 primer as described for the
Marathon1 cDNA Ampli¢cation kit (Clontech). The RACE products
were sequenced and the cDNA sequence informations of the 3P- and
5P-ends were included for the design of two new oligonucleotide prim-
ers ChlaBF (5P-GCAGACCAGTACGACATAATGATG-3P) and
ChlaBR (5P-TATAAAACAATAATGACTGCGACCTTC-3P) that
were used in PCR ampli¢cation of the entire chlamysin cDNA gene
using the high-¢delity Pfu DNA polymerase (Stratagene). PCR prod-
ucts were cloned in a plasmid vector of the pCR-Script1 Amp SK(+)
Cloning kit (Stratagene), and both strands of the cloned PCR prod-
ucts were sequenced using primers for vector-contained sequences as
well as gene-speci¢c primers.
2.6. Computer analysis
DNA and translation product sequence analysis were performed
mainly by programs in the Wisconsin Package Version 10.0, Genetics
Computer Group, Madison, WI, USA. Protein homology searches
and protein sequence alignments were done by the programs BLAST
[26] and ClustalW [27], respectively. Predictions of a possible protein
signal for transport and a putative cleavage site were produced by
SignalP [28] and by PSORT II [29]. Finally, the GeneDoc program
[30] was used to prepare the multiple sequence alignments for presen-
tation.
3. Results
3.1. Isolation and analysis of chlamysin
The puri¢ed chlamysin protein obtained after size-exclusion
chromatography appeared as a single band of Mr V11 kDa
after SDS-PAGE and Coomassie-staining (not shown). The
amino acid composition analysis (not shown) of chlamysin
indicated a protein containing about 100 amino acids includ-
ing one methionine and a high portion of cysteines (11%),
serines (10%) and histidines (7%). N-terminal sequence anal-
ysis of the puri¢ed chlamysin revealed a sequence of the ¢rst
30 residues. Later, and due to the presence of one methionine,
CNBr was used to cleave the reduced and alkylated protein.
RP-HPLC revealed that this produced three protein fragments
of which two were shown to be sequence homologs of the
initial N-terminal part of the protein. The third fragment of
chlamysin produced a sequence of 29 residues representing the
C-terminus of the chlamysin protein. The protein sequences
shown in Fig. 1A demonstrate a few ambiguities observed in
the three separately performed N-terminal sequencing analy-
ses. The isolated chlamysin lacks a methionine in the start of
the protein which strongly suggests that the protein has been
processed by the removal of a signal peptide starting with a
methionine residue.
3.2. cDNA gene isolation and sequencing analysis
Degenerated primer sequences derived from back-transla-
tion of the amino acid sequence of the chlamysin protein
(see Fig. 1A) de¢ned a PCR product of 290 bp when applied
in the ampli¢cation of the scallop cDNA template (not
shown). Based on the DNA sequence of the PCR product,
5P- and 3P-cDNA ends were subsequently produced in sepa-
rate RACE reactions, and a ¢nal PCR ampli¢cation of the
entire gene and its £anking cDNA ends was performed. The
DNA sequence presented in Fig. 1B includes a 411 bp open
reading frame of a 137 amino acid polypeptide which com-
prises sequences determined for the chlamysin protein frag-
ments. Six nucleotide positions were found to carry two alter-
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nating nucleotides in each of the six positions in the cDNA.
These variations, interpreted to be allelic forms present in the
scallops, produced four amino acid changes (positions 7, 12,
18 and 28) in the deduced protein. The sequenced chlamysin
protein, puri¢ed from extracts of a huge number of scallops,
indicates the existence of a few additional amino acid varia-
tions that possibly are not encoded by the six scallop individ-
uals used as source in the gene isolation.
Two sequence analysis programs gave statistical support of
an N-terminal 17 amino acid residue transport signal in chla-
mysin. According to these predictions, the secretion signal is
cleaved o¡ regardless of which of two amino acids (alanine or
serine) is present as residue 18. This assumably secreted chla-
mysin protein has a calculated molecular mass of 13 kDa, a
net charge of 32 and an isoelectric point of 6.9. The protein
has a particular high number of cysteines, serines and histi-
dines (14, 14 and 9, respectively) that in sum make up almost
30% of the total amino acid content of chlamysin. No ‘signa-
tures’ or ‘motifs’ of any known classes of enzymes are recog-
nized in the chlamysin primary structure.
Searches in accessible databases revealed no published se-
quence homologous of the chlamysin gene. In contrast, the
protein displays partial identity to a 123 residues bivalve ly-
sozyme (58% in 119 residues overlap) recently reported to
belong to a novel class of lysozymes [15], to destabilase 2
(60% in 109 residues overlap) which is a 136 residue endo-
O(Q-Glu)-Lys isopeptidase from the leech Hirudo medicinalis
[31], and to several hypothetical proteins of similar size
from Caenorhabditis elegans (46% in 129 amino acid residues
overlap to the C45G7.3 protein) [32]. A multisequence align-
ment of chlamysin and the three homologous proteins is
shown in Fig. 1C. Except for a gapping of seven residues
caused by a short non-homologue part of the C. elegans pro-
tein, a remarkable high degree of amino acid conservations is
seen in these four invertebrate proteins. Less signi¢cant ho-
mology was found to various lysozymes like the pigeon egg
white lysozyme (32% in 70 residues overlap) [33].
3.3. Enzymatic properties and protein stability
The speci¢c activity of the isolated scallop chlamysin
against M. luteus cells was 5U105 U/mg protein at pH 5.2
and ionic strength 0.1. At a low concentration of enzyme in
assay (0.1^5 ng/ml), chlamysin resembles conventional lyso-
zymes in degrading M. luteus cells at a linear rate. At higher
concentrations of chlamysin in assay, however, the activity
decreased with time, indicating a product inhibitory e¡ect
(Fig. 2A). In contrast, HEWL degraded the bacterial suspen-
sion at a constant rate. Chlamysin hydrolyzes M. luteus cells
Fig. 1. Protein and cDNA sequences of chlamysin and multisequence alignment of homologs. A: N-terminal amino acid sequence of the puri-
¢ed protein and of the fragment obtained by CNBr splitting. The N-terminus was sequenced three times and ambiguous residues are subse-
quently presented in brackets. Denotions below the sequences mark the amino acids applied in back-translations to DNA for design of two de-
generated oligonucleotides chlaN4 and chlaCT used to prime the initial PCR ampli¢cation of a part of the chlamysin cDNA gene. B: The
cDNA sequence and the deduced polypeptide encoded by the gene. A predicted 17 amino acid signal peptide is written in italics and the part
of the protein believed to constitute the active protein is shown in bold. Stop in translation is marked by an asterisk. The following nucleotide
position ambiguities were observed: T or C in position 37, G or A in position 52, G or C in position 69, T or C in position 70, and C or G
in position 102. C: Multisequence alignment of chlamysin and its homologs. The chlamysin protein sequence deduced from the cDNA gene of
C. islandica and the top three sequence homologs were aligned using ClustalW [27]. The homologs are the bivalve lysozyme from T. japonica
[15], destabilase 2 (GenBank accession U24122 under the name of destabilase I) from H. medicinalis [31] and the hypothetical gene product
C45G7.3 (SwissProt entry O76357) from C. elegans [32]. Chlamysin may carry one or more of the following amino acid substitutions: Leu-7,
Thr-12, Ala-18, Gln or Gly-28, Ala-29, Tyr-30, Arg-36, Gly-39 or Ser-40. The chlamysin nucleotide sequence has been assigned the EMBL
database accession number AJ250028.
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with the resultant liberation of reducing groups and N-acetyl-
amino sugars (Table 1), indicating a cleavage of the L-1,4
linkage between N-acetylmuramic acid (NAM) and N-acetyl-
glucosamine (NAG). The reaction catalyzed by chlamysin
produced only 25% and 50% of reducing groups and released
acetylamino sugars, respectively, compared to the amounts
produced by HEWL. The scallop enzyme at a concentration
of 15 Wg/ml did not exert detectable chitinase activity in the
assay systems used in which the same amounts of HEWL
were measured to have a chitinolytic activity (results not
shown).
The pH optimum conditions at ionic strength of 0.03^0.1
for the hydrolyzing activity of chlamysin are shown in Fig.
2B. No hydrolysis of the M. luteus suspension was produced
by the protein at neutral or basic pH. The enzyme activity of
chlamysin was studied at temperatures ranging from 4 to 40‡C
by adding 1 Wl samples to pre-heated M. luteus suspensions
(Fig. 2C). Chlamysin showed a remarkable high initial cata-
lytic activity at low temperature and the activity declined
above 25‡C. The temperature-dependent enzyme activity of
chlamysin is not a re£ection of thermal instability since pre-
incubation of chlamysin at 70‡C for 15 min has no e¡ect on
the hydrolyzing activity of the enzyme (not shown). We ob-
served only 20% loss of activity in a dilute chlamysin prepa-
ration (2.6 Wg/ml) after storage at 23‡C for 1 month (not
shown), a feature which suggests a high structure stability of
the protein.
3.4. Antibacterial activity of chlamysin
The extract prepared from viscera of scallops had previ-
ously been shown to contain in vitro antibacterial activities
to a few ¢sh-pathogens tested [19]. We therefore wanted to
verify potential growth-inhibiting e¡ects of the isolated chla-
mysin against various bacteria with preference to some that
mainly are associated with infection diseases in humans and
animals. Thus, seven strains of clinically relevant bacteria and
one ¢sh-pathogen were selected by convenience, representing
both Gram-positives and Gram-negatives. Moderate concen-
trations (2^10 WM) of chlamysin totally inhibited growth of all
bacteria (Table 2). No convincing di¡erences in response to
chlamysin are seen between the two Gram-staining groups of
bacteria, but the Gram-positives are possibly slightly more
susceptible than the Gram-negatives. We have not yet estab-
lished the mechanism of antibacterial activity mediated by
chlamysin.
4. Discussion
The data presented in this report show that the crystalline
style, a rod-like structure located in association with the di-
gestive gland in marine bivalves [34], contains a novel 11 kDa
lysozyme-like chlamysin protein with antibacterial activities.
Chlamysin isolated from the viscera of C. islandica inhibits the
growth of several bacteria causing infections in humans and
animals. The isolated antibacterial protein displays low-tem-
perature lysozyme-like M. luteus-hydrolyzing activity only at
acidic pH, but the enzyme lacks chitinase activity. A partly
puri¢ed 18 kDa lysozyme from the mussel Mytilus edulis [35]
Fig. 2. M. luteus-hydrolyzing activities. A: Time course of activities
at pH 5.2 and ionic strength of 0.1 using 0.5 Wg of chlamysin (F)
and HEWL (a). B: pH-dependent lysis by chlamysin at ionic
strength 0.1 (F) and 0.03 (R) compared to HEWL at ionic strength
0.1 (a). All values are normalized to the activity of HEWL at pH
7.2 (100%) and indicate relative speci¢c activities. C: E¡ect of tem-
perature on chlamysin activity. Assays were performed at pH 6.5
and ionic strength of 0.03.
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was previously shown to hydrolyze M. luteus in acidic or
neutral environments at moderate temperatures [36]. The re-
cently reported 13 kDa marine bivalve lysozyme from T. ja-
ponica demonstrates many features that resemble those of
HEWL, including chitinase activity and high optimal temper-
ature for lysozyme activity [15]. Chlamysin and the T. japon-
ica enzymes have M. luteus-hydrolyzing activities several fold
higher than HEWL. Our studies also revealed that the reac-
tion product of the M. luteus degradation inhibits the lyso-
zyme-like activity of chlamysin.
The full-length cDNA gene of chlamysin encodes 137 ami-
no acids, and after removal of the signal peptide, the trans-
lation product is predicted to have a molecular weight of
13 kDa. Analysis of the total amino acid composition of the
puri¢ed protein, however, shows that the enzyme including
the antibacterial activities is contained by a polypeptide of
approximately 100 amino acid residues. Results from sequenc-
ing the C-terminal CNBr fragment suggested that the active
protein ends with a glutamate residue corresponding to posi-
tion 121 of the cDNA translation product. The N-terminus of
the puri¢ed protein was found to start with an alanine and
this is in agreement with the start of the allelic cDNA trans-
lation products after the predicted removal of a 17 amino acid
signal sequence. A polypeptide like the cDNA-encoded pro-
tein from position 18 to 121 has a theoretical Mr of 11.4 kDa
which is compatible with the V11 kDa migration of the pu-
ri¢ed chlamysin in SDS-PAGE and with the approximately
100 amino acids estimated from the composition analysis.
Thus, the combined protein and cDNA sequence data indicate
that the mature and active chlamysin is a secreted protein of
104 amino acids with a primary structure identical to the
cDNA-derived polypeptide sequence starting at residue 18
and ending with residue 121. At present, we have no speci¢c
proposition for a potential protease involved in the removal of
a 16 amino acid residues C-terminal fragment from the trans-
lation product.
Several mollusk lysozymes [37] have been shown to have
high sequence homology to a lysozyme in the star¢sh Asteria
rubens [38] although the available sequence information was
limited to the N-terminal part of the proteins. These inverte-
brate enzymes were said to belong to a new lysozyme family.
Recently, three new invertebrate lysozymes were reported [15]
and all have partial sequence homology to the N-terminal
fragment of the star¢sh lysozyme [38]. A surprisingly high
identity in primary structures was found between the T. ja-
ponica lysozyme [15] and two other invertebrate proteins
which have no previous records of lysozyme protein relation-
ships; the destabilase 2 from H. medicinalis [31] and the hypo-
thetical gene product of CELF22A3.6 in C. elegans [32]. The
authors concluded that their results demonstrate a novel in-
vertebrate class of the lysozyme family. Chlamysin scores high
homology to the T. japonica lysozyme, to destabilase 2 and to
several putative C. elegans proteins. The group of homologous
proteins has conserved structurally important amino acid res-
idues and has with a few exceptions a ¢xed distance between
the conserved residues as also discussed by Ito et al. [15]. In
particular, the high content of cysteines and a consequently
potential of forming several intramolecular disul¢de bridges in
these proteins point to a class of structurally stable molecules.
Cold-active enzymes are believed to need a high degree of
structural £exibility to retain their activities at low temper-
atures in contrast to the expected rigidity of thermophilic
enzymes (reviewed in [39]). In this perspective, the cold-active
and highly stable chlamysin seems like a paradox.
Sequence homologies between the Japanese bivalve lyso-
zyme [15] and the arctic scallop protein in this study could
indicate homologous activities as well. There are, however,
several distinct enzymatic characteristics that distinguish these
two enzymes. The T. japonica lysozyme and HEWL have
several common features such as high lysozyme activity at
neutral pH, high optimal temperature (about 70‡C) and a
contained chitinase activity [15]. In contrast, chlamysin lacks
chitinase activity, has no bacteriolytic activity at neutral or
higher pH and the enzyme displays low-temperature hydro-
lyzing activity. The observed product inhibition of chlamysin
has not been reported for HEWL or the T. japonica lysozyme.
An apparent contradiction in the ¢nding of a high initial rate
of M. luteus hydrolysis and a low e⁄cient generation of lyso-
zyme-speci¢c reaction products by chlamysin could be ex-
plained by product inhibition due to a much higher concen-
tration of chlamysin used in the product analysis assay
compared to the amount used in the kinetic study experi-
ments. An alternative explanation is that chlamysin possesses
enzyme activities additional to the L-1,4 NAM-NAG hydro-
lase activity. The primary structure of chlamysin is similarly
homologous to the T. japonica lysozyme and to destabilase 2.
Although not convincing to Ito et al. [15], destabilase 2 was
shown to have an endo-O(Q-Glu)-Lys isopeptidase activity [31].
Thus, primary structure data relate chlamysin to a lysozyme,
as well as to an isopeptidase. Taking in consideration several
described non-lysozyme features of chlamysin, we hesitate to
classify chlamysin among lysozymes until future studies have
examined the hydrolyzing activities of chlamysin.
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